{"organizations": [], "uuid": "be3c96e1593e3d526c5d9c2d25fe4c02e57d6426", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180118.html", "section_title": "Archive News &amp; Video for Thursday, 18 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/health-flonase/u-s-chamber-backs-gsk-bid-to-reverse-ruling-allowing-louisiana-lawsuit-idUSL1N1PD0K6", "country": "US", "domain_rank": 408, "title": "U.S. Chamber backs GSK bid to reverse ruling allowing Louisiana lawsuit", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-18T20:59:00.000+02:00", "replies_count": 0, "uuid": "be3c96e1593e3d526c5d9c2d25fe4c02e57d6426"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/health-flonase/u-s-chamber-backs-gsk-bid-to-reverse-ruling-allowing-louisiana-lawsuit-idUSL1N1PD0K6", "ord_in_thread": 0, "title": "U.S. Chamber backs GSK bid to reverse ruling allowing Louisiana lawsuit", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "louisiana", "sentiment": "none"}, {"name": "philadelphia", "sentiment": "none"}], "organizations": [{"name": "glaxosmithkline", "sentiment": "negative"}, {"name": "u.s. chamber of commerce", "sentiment": "negative"}, {"name": "gsk", "sentiment": "negative"}, {"name": "westlaw", "sentiment": "none"}, {"name": "3rd u.s. circuit court of appeals", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "The U.S. Chamber of Commerce is supporting GlaxoSmithKline’s bid to overturn a court decision allowing the state of Louisiana to bring antitrust claims against the drugmaker even though it did not opt out of a related, previous class action settlement.\nThe Chamber filed a brief on Tuesday asking the full 3rd U.S. Circuit Court of Appeals in Philadelphia to review a three-judge panel’s decision holding Louisiana’s sovereign immunity meant it was not bound by a deal resolving claims that GSK tried to delay generic versions of its allergy drug Flonase.\nTo read the full story on Westlaw Practitioner Insights, click here: bit.ly/2mST6yO\n ", "external_links": ["http://bit.ly/2mST6yO", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-18T20:59:00.000+02:00", "crawled": "2018-01-19T12:17:05.000+02:00", "highlightTitle": ""}